| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Chlorothiazide sodium |
Is a |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
|
| Chlorothiazide measurement |
Component |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Accidental chlorothiazide poisoning |
Causative agent (attribute) |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
|
| Intentional chlorothiazide poisoning |
Causative agent (attribute) |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
|
| intoxication par la chlorothiazide d'intention indéterminée |
Causative agent (attribute) |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide adverse reaction |
Causative agent (attribute) |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Allergy to chlorothiazide (finding) |
Causative agent (attribute) |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
|
| Chlorothiazide overdose |
Causative agent (attribute) |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Accidental chlorothiazide overdose |
Causative agent (attribute) |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Intentional chlorothiazide overdose |
Causative agent (attribute) |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| surdose de chlorothiazide d'intention indéterminée |
Causative agent (attribute) |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
|
| Chlorothiazide 250 mg and reserpine 125 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
|
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
|
| Chlorothiazide 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
|
| Poisoning by chlorothiazide |
Causative agent (attribute) |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Product containing chlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 250 mg and methyldopa 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
|
| Product containing chlorothiazide and reserpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Product containing chlorothiazide and methyldopa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorothiazide 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
|
| Chlorothiazide 500 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
|
| Accidental chlorothiazide poisoning |
Causative agent (attribute) |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
2 |
| Intentional chlorothiazide poisoning |
Causative agent (attribute) |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
2 |
| Product containing chlorothiazide and spironolactone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Allergy to chlorothiazide (finding) |
Causative agent (attribute) |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 250 mg and reserpine 125 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 250 mg and methyldopa 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 250 mg and methyldopa 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
2 |
| Chlorothiazide 250 mg and reserpine 125 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 250 mg and reserpine 125 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 250 mg and methyldopa 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 250 mg and reserpine 125 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Chlorothiazide (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Product containing chlorothiazide and reserpine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Product containing chlorothiazide and methyldopa in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorothiazide 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorothiazide 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide and methyldopa only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Product containing only chlorothiazide and reserpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Product containing only chlorothiazide and spironolactone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide and methyldopa only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Product containing only chlorothiazide and reserpine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Product containing only chlorothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide sodium |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
|
| Chlorothiazide 500 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 500 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
| Chlorothiazide 250 mg and reserpine 125 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorothiazide (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]